Saturday 17 October 2026
Export NIVF’s income statement to Excel — free account
NewGenIvf Group Limited
NIVF Healthcare Medical Care Facilities
NewGenIvf Group Limited’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 13.0% from fiscal 2024. Dividend growth for five consecutive years; insiders bought in the last twelve months.
0.28
0.03
+12.00%
Follow NIVF
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | 21,211,200.00 | 20,623,680.00 | 518,400.00 | 263.52 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | 22,658,400.00 | 25,876,800.00 | 37,238,400.00 | 1,058,400.00 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 70 | 76 | 87 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | 0.00 | 0.07 | 0.07 | 0.05 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | 6 | 5 | 5 | 5 | ||||
| Gross margin, % | — | — | — | — | — | — | 25.87 | 32.74 | 33.62 | 20.22 | |||||
| EBT | — | — | — | — | — | — | 0 | 0 | (1) | 10 | |||||
| EBT margin, % | — | — | — | — | — | — | 5.79 | 2.11 | (17.68) | 205.84 | |||||
| Net income | — | 0 | — | — | — | 0 | 0 | 0 | 0 | 10 | |||||
| Depreciation | — | — | — | — | — | — | 0 | 0 | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | 10.32 | 0.00 | 0.00 | 926.75 | ||||
| Earnings | — | — | — | — | — | — | 138,203.20 | 14,079.32 | (35,650.70) | 1,932.96 | |||||
| Cash flow | — | — | — | — | — | — | 2.97 | 0.00 | 0.00 | (2,142.37) | |||||
| Capex | — | — | — | — | — | — | (0.16) | 0.00 | 0.00 | (26.47) | |||||
| Free cash flow | — | — | — | — | — | — | 2.81 | 0.00 | 0.00 | (2,168.84) | |||||
| Book value | — | — | — | — | — | — | 0.17 | 0.00 | 0.00 | 5,095.43 | |||||
| Shares, m | — | — | — | — | — | — | 1 | 0 | 0 | 0 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | ||||
| P/S | — | — | — | — | — | — | — | — | — | — | |||||
| P/B | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| EV/FCF | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.17) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | 2 | (2) | (8) | (11) | ||||
| Capex | — | — | — | — | — | — | 0 | 0 | 0 | 0 | |||||
| Free cash flow | — | — | — | — | — | — | 2 | (2) | (8) | (11) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | 0 | 1 | 0 | 5 | ||||
| Total debt | — | — | — | — | — | — | 0 | — | 2 | 4 | |||||
| Net debt | — | — | — | — | — | — | 0 | 0 | 2 | 3 | |||||
| Shareholders’ equity | — | — | — | — | — | — | 0 | 3 | (1) | 26 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | 31.58 | 3.52 | (13.01) | 54.43 | ||||
| ROIC | — | — | — | — | — | — | 313.44 | 0.83 | (186.26) | (22.86) | |||||
| ROE | — | — | — | — | — | — | 0.00 | 7.78 | (59.49) | 80.63 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · fundamentals updated 9 Oct 2026
Charts ten years each
NewGenIvf Group Limited vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| CCM Concord Medical Services Holdings Limited | $10.5M | — (loss-making) | — (loss-making) | +37.65% (above 0%: growing) | n/m | −281.45% (below 0%: shrinking) | (13.15%) | 0.00% | Compare |
| AMS American Shared Hospital Services | $8.4M | — (loss-making) | 1.8× | +19.22% (above 0%: growing) | n/m | +195.82% (above 0%: growing) | 17.00% | (7.22%) | Compare |
| CANOQ Cano Health, Inc. | $6.6M | — (loss-making) | — | −21.05% (below 0%: shrinking) | n/m | −43.68% (below 0%: shrinking) | 100.00% | (16.23%) | Compare |
| MODVQ ModivCare Inc. | $6.2M | — (loss-making) | — (loss-making) | −3.18% (below 0%: shrinking) | n/m | −3,767.70% (below 0%: shrinking) | 14.06% | (1.78%) | Compare |
| BMGL Basel Medical Group Ltd | $6.2M | — | — | — | — | — | — | — | Compare |
| RHEP Adcare Health Systems Inc | $5.2M | 0.6× | — (loss-making) | +143.03% (above 0%: growing) | n/m | +224.45% (above 0%: growing) | 31.50% | (0.88%) | Compare |
| NIVF NewGenIvf Group Limited | $2.3M | — | — | — | — | — | — | — | |
| SYRA Syra Health Corp. | $1.1M | 84.0× | — | +23.03% (above 0%: growing) | n/m | −892.68% (below 0%: shrinking) | 44.53% | 10.51% | Compare |
| NVOS Novo Integrated Sciences, Inc. | $730.0K | — (loss-making) | — (loss-making) | −6.74% (below 0%: shrinking) | −43.27% (below 0%: shrinking) | −111.85% (below 0%: shrinking) | 51.21% | (87.60%) | Compare |
| Median of peers | $6.2M | — | — | +19.22% | — | −111.85% | 31.50% | (1.78%) |
NewGenIvf Group Limited (NIVF) key facts
- Concern: NewGenIvf Group Limited’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 13.0% from fiscal 2024.
- NewGenIvf Group Limited (NIVF) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, NIVF traded at $0.28, a market capitalization of $2.3 million.
- Return on equity was 80.6% and debt-to-equity 0.00.
- Its Altman Z-score is −0.24 (distress zone) for fiscal 2025.